After Excedrin products were pulled from shelves last January due to manufacturing problems, parent Novartis says the date for re-release has been pushed to the fourth quarter of 2012. In the meantime, several of Johnson & Johnson’s Tylenol products are still in short supply after three years of voluntary recalls.